FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

73579000: Carbidopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
122178011 Carbidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
122179015 MK-486 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3736797013 Alpha-methyldopa hydrazine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
122178011 Carbidopa en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
122178011 Carbidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
122179015 MK-486 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
122180017 alpha-Methyldopa hydrazine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
813982014 Carbidopa (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
813982014 Carbidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3736797013 Alpha-methyldopa hydrazine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51091000195114 carbidopa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66221000195116 Carbidopa de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
797681000172110 carbidopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
797681000172110 carbidopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
51091000195114 carbidopa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66221000195116 Carbidopa de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa Is a Co-careldopa false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Is a Antiparkinsonian agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Is a Co-careldopa false Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Is a Dihydroxyphenylalanine true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Is a Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Has disposition Dopamine receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Has disposition Dihydroxyphenylalanine decarboxylase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa Is a produit chimique catégorisé selon sa fonction false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbidopa measurement Has measured component False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa measurement Component True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Levodopa with carbidopa The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa 10mg/100mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa 25mg/100mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa 25mg/250mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa 50mg/200mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa 25mg/100mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa + levodopa 50mg/200mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa + levodopa 25mg/100mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing carbidopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing carbidopa and levodopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa+levodopa+entacapone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Co-careldopa Is a False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa + levodopa adverse reaction Causative agent (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Allergy to carbidopa and levodopa Causative agent (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing carbidopa and levodopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa monohydrate (substance) Is a False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing carbidopa and levodopa in enteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing carbidopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet Has precise active ingredient False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa monohydrate (substance) Is modification of (attribute) True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to carbidopa and levodopa Causative agent (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Carbidopa only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only carbidopa and entacapone and levodopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only carbidopa and levodopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only carbidopa and levodopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa and levodopa only product in enteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only carbidopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa anhydrous (substance) Is modification of (attribute) True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa- and levodopa-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has basis of strength substance (attribute) True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa anhydrous (as carbidopa) 25 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet Has precise active ingredient True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Carbidopa Inferred relationship Existential restriction modifier (core metadata concept) 3

Page 1 of 2 End

This concept is not in any reference sets

Back to Start